TRACON PHARMACEUTICALS

YTD

ALL

Why Robinhood?

You can watch TCON and buy or sell other stocks, ETFs, and their options commission-free!

About TCON

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma.

CEO

Craig R. Jalbert

CEOCraig R. Jalbert

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2004

Founded2004

Employees

—

Employees—

TCON Key Statistics

Market cap

109.72K

Market cap109.72K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

9.02K

Average volume9.02K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$14.75

52 Week high$14.75

52 Week low

$0.002

52 Week low$0.002